A collection of cancer statistics and facts
By Matthew Mahady
Advertisement
Articles by By Matthew Mahady
Physicians' Financial News focuses on newsworthy and/or notable companies in the oncology/biotech sector. In this issue:1) Genentech: Continues to Grow Oncology Portfolio2) ImClone: Erbitux News Initially Raise ImClone Shares3) AstraZeneca: Prostate Drug Enters Phase II4) Kiadis Pharma: One Blood Cancer Treatment Clears Phase II Hurdles, Another May Hit Market By 20095) Big Pharma Stocks Show Signs of Life
Advertisement
Latest Updated Articles
- Fast Facts: New Cancer Survival Data
Published: June 29th 2010 | Updated:
- Fast Facts
Published: June 23rd 2010 | Updated:
- Fast Facts: Skin Cancer and Melanoma
Published: June 25th 2010 | Updated:
- FDA Grants Priority Review to Potential Liver Cancer Therapy
Published: June 30th 2010 | Updated:
- Pfizer Continues Transformation; Stakes Future on New Direction
Published: May 24th 2010 | Updated:
- Rapid Pace of Oncology Industry Consolidation Continues: Pfizer's Sights on Bayer, ImClone Runs from BMS to Eli Lilly
Published: May 24th 2010 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5